Shares of coronavirus stock Inovio Pharmaceuticals INO surged again on Tuesday. INO was up about 18% in late-morning trading and ended the trading day up 20.4% to $13.63.
There’s no specific news driving the stock, but investors are expecting new updates for its Covid-19 vaccine candidate INO-4800 soon. The biotech is awaiting FDA clearance to begin phase 2/3 trials in the US, which it anticipates will happen soon. CEO Joseph Kim also said that Inovio is “very confident” it will receive funding for the upcoming vaccine trials
INO has soared 300% year-to-date, and is up about 85% since the March market lows.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Inovio Pharmaceuticals, Inc. (INO): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
